{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:21:09Z","timestamp":1794493269057,"version":"4.9.1"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100001125","name":"Gavi Alliance","doi-asserted-by":"publisher","award":["Agreement No.760203"],"award-info":[{"award-number":["Agreement No.760203"]}],"id":[{"id":"10.13039\/100001125","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12879-016-1758-x","type":"journal-article","created":{"date-parts":[[2016,8,12]],"date-time":"2016-08-12T07:18:22Z","timestamp":1470986302000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh"],"prefix":"10.1186","volume":"16","author":[{"given":"Md Jasim","family":"Uddin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gourab","family":"Adhikary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Wazed","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahabuddin","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md","family":"Shamsuzzaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Odell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Hashiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurul","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,12]]},"reference":[{"key":"1758_CR1","volume-title":"The Immunological Basis for Immunization Series, Module 7: Measles","author":"FT Cutts","year":"1993","unstructured":"Cutts FT. The Immunological Basis for Immunization Series, Module 7: Measles. Geneva: WHO Gpfvai; 1993."},{"key":"1758_CR2","unstructured":"Hutchins SS, Redd SC, Schrag S, et al. National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994. MedGenMed. 2001: E5."},{"issue":"35","key":"1758_CR3","first-page":"349","volume":"84","author":"World Health Organization Measles vaccines","year":"2009","unstructured":"World Health Organization Measles vaccines. WHO position paper. Wkly Epidemiol Rec. 2009;84(35):349\u201360.","journal-title":"Wkly Epidemiol Rec"},{"issue":"29","key":"1758_CR4","first-page":"301","volume":"86","author":"World Health Organization","year":"2011","unstructured":"World Health Organization. Rubella vaccines: WHO position paper. Wkly Epidemiol Rec. 2011;86(29):301\u201316.","journal-title":"Wkly Epidemiol Rec"},{"key":"1758_CR5","unstructured":"World Health Organization. Global Measles and Rubella Strategic Plan 2012-2020. 2012. http:\/\/apps.who.int\/iris\/bitstream\/10665\/44855\/1\/9789241503396_eng.pdf . Accessed 17 Jan 2015."},{"key":"1758_CR6","unstructured":"Directorate General of Health Services (DGHS). EPI Surveillance Bulletin. 2013. Available from: http:\/\/www.dghs.gov.bd\/images\/docs\/EPI\/Bulletin%20for%20EPI%20Web%20Site\/2013\/EPI%20Surveillance%20Bulletin-Issue%2001-2013.pdf . Accessed 17 Jan 2015."},{"key":"1758_CR7","unstructured":"GAVI Alliance. Over 700 million children in 49 countries to be protected against measles and rubella. 2013. Available from: http:\/\/www.gavialliance.org\/library\/news\/press-releases\/2013\/over-700-million-children-in-49-countries-to-be-protected-against-measles-and-rubella\/ . Accessed 14 July 2013."},{"key":"1758_CR8","doi-asserted-by":"crossref","unstructured":"Koehlmoos TP, et al. Impact of measles eradication activities on routine immunization services and health systems in Bangladesh. J Infect Dis. 2011;204:S90\u20137.","DOI":"10.1093\/infdis\/jir086"},{"key":"1758_CR9","unstructured":"World Health Organization. Immunization, Vaccines and Biological: Over 700 million children in 49 countries to be protected against measles and rubella. 2013. Available from: http:\/\/www.who.int\/immunization\/newsroom\/press\/700_million_children_49_countries_protected_measles_rubella\/en\/ . Accessed 14 July 2013."},{"issue":"1","key":"1758_CR10","first-page":"1","volume":"15","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. Bangladesh introduces new MR and MCV2 vaccine to prevent Measles, Rubella & (Congenital Rubella Syndrome. EPI Surveillance bulletin. 2012;15(1):1\u20135.","journal-title":"EPI Surveillance bulletin"},{"key":"1758_CR11","volume-title":"EPI Fact Sheet: Bangladesh 2011","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. EPI Fact Sheet: Bangladesh 2011. 2012."},{"issue":"Supplement 2","key":"1758_CR12","doi-asserted-by":"crossref","first-page":"B115","DOI":"10.1016\/j.vaccine.2012.11.094","volume":"31","author":"R Fields","year":"2013","unstructured":"Fields R, Dabbagh A, Jain M, Sagar KS. Moving forward with strengthening routine immunization delivery as part of measles and rubella elimination activities. Vaccine. 2013;31(Supplement 2):B115\u201321.","journal-title":"Vaccine"},{"issue":"Supplement 1","key":"1758_CR13","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.1086\/368055","volume":"187","author":"S Bino","year":"2003","unstructured":"Bino S, et al. Measles-rubella mass immunization campaign in Albania, November 2000. J Infect Dis. 2003;187(Supplement 1):S223\u20139.","journal-title":"J Infect Dis"},{"key":"1758_CR14","volume-title":"EPI coverage evaluation survey-2013","author":"Directorate General of Health Services (DGHS)","year":"2013","unstructured":"Directorate General of Health Services (DGHS). EPI coverage evaluation survey-2013. Government of Bangladesh: Ministry of Health and Family Welfare; 2013."},{"issue":"4","key":"1758_CR15","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1467-842X.1998.tb01411.x","volume":"22","author":"L Bond","year":"1998","unstructured":"Bond L, et al. Vaccine preventable diseases and immunisations: a qualitative study of mothers? Perceptions of severity, susceptibility, benefits and barriers. Aust N Z J Public Health. 1998;22(4):441\u20136.","journal-title":"Aust N Z J Public Health"},{"issue":"4","key":"1758_CR16","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/heapol\/czp008","volume":"24","author":"WB Mbabazi","year":"2009","unstructured":"Mbabazi WB, et al. Achieving measles control: lessons from the 2002\u201306 measles control strategy for Uganda. Health Policy Plan. 2009;24(4):261\u20139.","journal-title":"Health Policy Plan"},{"key":"1758_CR17","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1093\/infdis\/jir091","volume":"204","author":"P Hanvoravongchai","year":"2011","unstructured":"Hanvoravongchai P, Mounier-Jack S, Cruz VO, et al. Impact of Measles Elimination Activities on Immunization Services and Health Systems: Findings From Six Countries. J Infect Dis. 2011;204:S82\u20139.","journal-title":"J Infect Dis"},{"key":"1758_CR18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.9745\/GHSP-D-13-00130","volume":"2","author":"S Mounier-Jack","year":"2014","unstructured":"Mounier-Jack S, Burchett HED, Ulla Kou G, Mamadou K, Kassibo Sira D. Meningococcal vaccine introduction in Mali through mass campaigns and its impact on the health system. Glob Health Sci Pract. 2014;2:117\u201329.","journal-title":"Glob Health Sci Pract"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-016-1758-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T16:35:30Z","timestamp":1498322130000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-016-1758-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,12]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1758"],"URL":"https:\/\/doi.org\/10.1186\/s12879-016-1758-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,12]]},"article-number":"411"}}